Nimrod A, Greenman B. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents: US, 4784991. 1988-11-15.
[2]
Pirc E T, Arcon I, Kodre A. Metalion environment in solid Mn(II),Co(II) and Ni(II) hyaluronates[J]. Carbohydr Res,2004,339(15):2549-2554.
[3]
Mercê A L, Marques Carrera L C, Santos Romanholi L K, et al. Aqueous and solid complexes of iron(III) with hyaluronic acid potentiometric titrations and infrared spectroscopy studies[J]. Inorg Biochem, 2002,89(3-4):212-218.
[4]
Pirc E T, Arcon I, Bukovec P. Preparation and characterisation of copper(II) hyaluronate[J]. Carbohydr Res, 2000,324(4):275-282.
[5]
Illés J, Jvor A, Szíjrtó E. Zinc-hyaluronate: ana original organotherapeutic compound of gedeon richter ltd[J]. Acta Pharm Hung, 2002,72(1):15-24.
[6]
Illés J, Matuz J, Neszmelyi E. Use of zinc hyaluronate against peptic ulcer: US, 6656921B1. 2003-12-02.
[7]
朱湛,窦晶晶,郭炳南,等.质酸金的合成及性质研究[J].北京理工大学学报,2011,31(8):988-990. Zhu Zhan, Dou Jingjing, Guo Bingnan, et al. Synthesis of Au(Ⅲ) hyaluronate and its properties[J]. Transactions of Beijing Institute of Technology, 2011,31(8):988-990. (in Chinese)
[8]
Moulabi M, Broch H, Robert L, et al. Quantum molecular modeling of hyaluronan[J]. Journal of Molecular Structure (Theochem),1997,395-396:477-508.
[9]
Burger K, Illés J, Gyurcsik B. Metal ion coordination of macromolecular bioligands: formation of zinc(II) complex of hyaluronic acid[J]. Carbohydr Res, 2001,332(2):197-207.
[10]
杨晓改,杨晓达,王夔.稀土药用研究的动向和问题[J].化学进展,2007,19(23):201-204. Yang Xiaogai, Yang Xiaoda, Wang Kui. Trends and problems in studies of rare-earths-based drugs[J]. Progress in Chemistry, 2007,19(23):201-204. (in Chinese)
[11]
Thompson K H, Orvig C. Editorial: lanthanide compounds for therapeutic and diagnostic applications[J]. Chem Soc Rev,2006,35:499.
[12]
Fricker S P. The therapeutic application of lanthanides[J]. Chem Soc Rev, 2006,35:524-533.
